Insights

Bryana McGillycuddy to Speak On CDMO Outsourcing at IPWatchdog Life Sciences Masters

Bryana McGillycuddy will speak on the panel, "The CDMO Surge and Potential IP Landmines in Outsourcing" at the IPWatchdog Life Sciences Masters 2024 on Monday, October 28th at 3:40 p.m.

Choate Represents Bank of America in Precedent-Setting Credit Facilities for Rite Aid Corporation

Representing Bank of America in connection with debtor-in-possession financings for Rite Aid Corporation and its subsidiaries, Choate secured final court approval for the largest ever retail and consumer product sector debtor-in-possession financing on December 22, 2023.

IPWatchdog Life Sciences Masters 2023 Takeaways

Key takeaways compiled by Choate attorneys who recently participated in the IPWatchdog Life Sciences Masters, which provided insights on the latest updates and trends in intellectual property law and the biopharmaceutical industry.

Bryana McGillycuddy Speaking on ANDA Litigation at the IP Watchdog Life Sciences Masters

Bryana McGillycuddy will be a panelist for the session, "ANDA Litigation: Current Trends and Best Practices" at the IP Watchdog 2023 Life Sciences Masters Conference on Wednesday, October 18, 2023.

Sophie Wang and Bryana McGillycuddy Named Rising IP Stars

Managing IP has recognized Sophie F. Wang and Bryana T. McGillycuddy as 2023 Rising IP Stars.

Bryana McGillycuddy Speaking at the Boston Bar Association's IP Year in Review 2023

Bryana McGillycuddy will be a speaker at the Boston Bar Association's Annual IP Year in Review conference on Thursday, March 23rd. Bryana, a member of the BBA's Intellectual Property Law Section Advisory Committee, will participate on the "Intellectual Property in Life Sciences" panel taking place at 2:05 p.m.

Key Considerations in Identifying PTAB-Specific Expert Witnesses

In this episode of Choate's IP Insights Podcast Series, Bryana McGillycuddy and Mandeep Kaur are joined by Drew Winship of Juristat to discuss best practices for identifying and retaining expert witnesses for PTAB proceedings.

FDA Issues Continued Guidance on Biosimilar Development and the BPCIA

The Biologics Price Competition and Innovation Act (“BPCIA”) created an abbreviated licensure pathway for biological products shown to be biosimilar to or interchangeable with an FDA-licensed biological reference product.  

Conducting Clinical Trials Part 1: When Should You File Your Patent Applications?

As the first installment of Choate’s Conducting Clinical Trials series, Bryana McGillycuddy and John Rearick discuss a range of implications associated with the timing of filing, including the validity of the patent and the risk of inadvertent disclosure.